Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Fein

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Neurochemical Research|August 30, 2002
Caspase inhibition protects nerve terminals from in vitro degradationKaren H Gylys, Jeffrey A Fein, Gregory M Cole
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 2, 2004
Enrichment of presynaptic and postsynaptic markers by size-based gating analysis of synaptosome preparations from rat and human cortexKaren H Gylys, Jeffrey A Fein, Fusheng Yang, et al.
Journal of Neurochemistry|March 5, 2003
Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminalsKaren H Gylys, Jeffrey A Fein, Aiko M Tan, et al.
Neurochemistry International|October 22, 2003
Rapid annexin-V labeling in synaptosomesKaren H Gylys, Jeffrey A Fein, Dorothy J Wiley, et al.
Neurobiology of Aging|December 8, 2005
Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortexKaren Hoppens Gylys, Jeffrey A Fein, Fusheng Yang, et al.
The American Journal of Pathology|October 29, 2004
Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescenceKaren Hoppens Gylys, Jeffrey A Fein, Fusheng Yang, et al.
The American Journal of Pathology|May 10, 2008
Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomesJeffrey A Fein, Sophie Sokolow, Carol A Miller, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Neurochemical Research|August 30, 2002
Caspase inhibition protects nerve terminals from in vitro degradationKaren H Gylys, Jeffrey A Fein, Gregory M Cole
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 2, 2004
Enrichment of presynaptic and postsynaptic markers by size-based gating analysis of synaptosome preparations from rat and human cortexKaren H Gylys, Jeffrey A Fein, Fusheng Yang, et al.
Journal of Neurochemistry|March 5, 2003
Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminalsKaren H Gylys, Jeffrey A Fein, Aiko M Tan, et al.
Neurochemistry International|October 22, 2003
Rapid annexin-V labeling in synaptosomesKaren H Gylys, Jeffrey A Fein, Dorothy J Wiley, et al.
Neurobiology of Aging|December 8, 2005
Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortexKaren Hoppens Gylys, Jeffrey A Fein, Fusheng Yang, et al.
The American Journal of Pathology|October 29, 2004
Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescenceKaren Hoppens Gylys, Jeffrey A Fein, Fusheng Yang, et al.
The American Journal of Pathology|May 10, 2008
Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomesJeffrey A Fein, Sophie Sokolow, Carol A Miller, et al.
Pageof 1